High Tower Advisors, LLC Mirati Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$144.0 - $179.73 $240,336 - $299,969	-1,669 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$158.92 - $221.61 $794 - $1,108	-5 Reduced 0.3%	1,669 $286,000
Q4 2020 Feb 10, 2021	BUY	$162.05 - $240.27 $271,271 - $402,211	1,674 New	1,674 $362,000
Q2 2019 Aug 13, 2019	SELL	$59.49 - $104.71 $211,189 - $371,720	-3,550 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $154,957 - $280,272	3,550 New	3,550 $260,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $136,000 - $201,577	-4,250 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $110,712 - $222,700	4,250 New	4,250 $209,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.